![](/img/cover-not-exists.png)
427 Plasma and urinary pharmacokinetics of the novel, oral SHIP1 activator, AQX-1125 in interstitial cystitis/bladder pain syndrome (IC/BPS): Results of the phase2 LEADERSHIP trial
Nickel, C., Evans, R., Tam, P., Toews, J., MacKenzie, L., Biagi, H., Shrewsbury, S.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60429-3
Date:
March, 2016
File:
PDF, 106 KB
english, 2016